Xencor reported $90.03M in Current Liabilities for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Alnylam Pharmaceuticals ALNY:US USD 772.79M 115.11M
Amgen AMGN:US USD 14.33B 1.71B
Arrowhead Research ARWR:US USD 128.21M 10.64M
AstraZeneca AZN:LN USD 24.85B 3.04B
Biogen BIIB:US USD 3.93B 1.09B
Bristol Myers Squibb BMY:US USD 18.93B 1.98B
Cytokinetics CYTK:US USD 76.5M 9.65M
GlaxoSmithKline GSK:LN GBP 20.95B 16.88B
Karyopharm Therapeutics KPTI:US USD 61.76M 780K
Macrogenics MGNX:US USD 50.05M 831K
Novartis NOVN:VX USD 28.16B 514M
Regeneron Pharmaceuticals REGN:US USD 2.88B 154.7M
Seattle Genetics SGEN:US USD 726M 117.48M
Xencor XNCR:US USD 90.03M 14.99M